SYRE
SYRE
NASDAQ · Biotechnology

Spyre Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$96.42
+8.08 (+9.15%)
As of Jun 22, 1:45 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 22 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target -18.1% upside
Low Target $58.92
Average Target $78.92
High Target $128.60
Current Price $96.42
Current
$96.42
Target
$78.92
$58.92 $78.92 avg $128.60
Scenario Analysis
Bear Case
$58.92
-38.9%
Low target
Base Case
$78.92
-18.1%
Avg target
Bull Case
$128.60
+33.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$90.99
6.0% from high
52-Week Low
$14.00
+588.7% from low
50-Day SMA
$33.24
+190.1% vs SMA
200-Day SMA
$22.06
+337.1% vs SMA
RSI (14)
64.7
Neutral
Target vs 52W High
$78.92
-13.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%